Results 121 to 130 of about 145,366 (199)

<i>In vitro</i> activity of robenidine analogue NCL195 against methicillin-resistant <i>Staphylococcus pseudintermedius</i>. [PDF]

Microbiol Spectr
Bista S, Nguyen HT, Soares da Costa TP, Woolford L, Blaskovich MAT, Veltman T, Young KA, McCluskey A, Siak M, Page SW, Venter H, Trott DJ, Ogunniyi AD.   +12 more
europepmc   +1 more source

Systematic and quantitative analyses of hollow fiber model of <i>Mycobacterium abscessus</i> lung disease studies and new dosing recommendations. [PDF]

Microbiol Spectr
Srivastava S, Gumbo T.
europepmc   +1 more source

Droplet microfluidics with image texture quantification for detection of rare antibiotic-resistant subpopulations from bloodstream infections. [PDF]

NPJ Digit Med
Agnihotri SN, Fatsis-Kavalopoulos N, Vikdahl E, Windhager J, Corbat AA, Andersson DI, Tenje M.   +6 more
europepmc   +1 more source

Heteroresistance to amikacin in <i>Klebsiella aerogenes</i> isolates from patients in an intensive care unit in Brazil. [PDF]

Microbiol Spectr
Crispim NR, Nunes GD, Soares GG, Shilling RE, Ferreira RL, Campos LC, Alcobaça OSA, Silva JPMdOd, Rodrigues SH, Pitondo-Silva A, Fuentes ASdC, Cunha AFd, Mitchell RJ, Pranchevicius M-CdS.   +13 more
europepmc   +1 more source

Antimicrobial susceptibility trends of WHO critical Gram-negative pathogens in Fijian Hospitals, 2016-2021. [PDF]

JAC Antimicrob Resist
Baleivanualala SC, Soqo V, Smita S, Sharma S, Devi SV, Delaitoga L, Maharaj K, Autar S, Racolo T, Vera N, Naivalu TK, Wilson D, Crump JA, Ussher JE.   +13 more
europepmc   +1 more source

6-methylflavone exerts selective antimycobacterial activity with membrane energetics disruption and demonstrates therapeutic potential against <i>Mycobacterium abscessus</i> infection. [PDF]

Microbiol Spectr
Oh J, Shin J-W, Seo H, Kim H-J, Kim N-J, Kim B-J.   +5 more
europepmc   +1 more source

Analysis of the impact of national centralized volume-based procurement drug policy on the market dynamics of tuberculosis drugs. [PDF]

BMC Health Serv Res
Yang J, Yu X, Yao Y, Zhao W, Chen Y, Wang Z, Xu M.   +6 more
europepmc   +1 more source

Evaluation of In Vitro Effects of Fosfomycin in Combination With Amikacin and Ciprofloxacin Against Multidrug-Resistant Escherichia coli Isolates. [PDF]

Cureus
Choudhury S, Panigrahi K, Panda SS, Pattnaik D, Sahoo JP.   +4 more
europepmc   +1 more source

Genetic variants of AcrAB and OqxAB and the impact of efflux pump inhibition on ciprofloxacin and amikacin resistance in clinical isolates of Klebsiella pneumoniae from Lima, Peru. [PDF]

BMC Microbiol
Aguilar-Luis D, Silva-Caso W, Pérez-Lazo G, Morales-Castillo L, Camps M, Soto-Febres F, Aguilar-Luis MA, Aquino-Ortega R, Del Valle-Mendoza J.   +8 more
europepmc   +1 more source

Amikacin exposure in MDR-TB patients in Uganda: Revisiting old drugs in a new era of resistance - A pharmacokinetic assessment. [PDF]

New Microbes New Infect
Hongler J, Haller S, Adakun AS, Lutz N, Buzibye A, Kälin M, Castelnuovo B, Sekaggya-Wiltshire C, Abongomera G, Jetter A, Fehr J.   +10 more
europepmc   +1 more source